Commonwealth Equity Services’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.13M | Buy |
8,215
+912
| +12% | +$125K | ﹤0.01% | 2462 |
|
|
2025
Q1 | $1.32M | Buy |
7,303
+2,437
| +50% | +$439K | ﹤0.01% | 2247 |
|
|
2024
Q4 | $762K | Buy |
4,866
+190
| +4% | +$29.8K | ﹤0.01% | 2615 |
|
|
2024
Q3 | $851K | Buy |
4,676
+52
| +1% | +$9.46K | ﹤0.01% | 2478 |
|
|
2024
Q2 | $849K | Buy |
4,624
+41
| +0.9% | +$7.53K | ﹤0.01% | 2404 |
|
|
2024
Q1 | $815K | Sell |
4,583
-1
| -0% | -$178 | ﹤0.01% | 2400 |
|
|
2023
Q4 | $569K | Buy |
4,584
+158
| +4% | +$19.6K | ﹤0.01% | 2589 |
|
|
2023
Q3 | $513K | Buy |
4,426
+110
| +3% | +$12.8K | ﹤0.01% | 2564 |
|
|
2023
Q2 | $507K | Hold |
4,316
| – | – | ﹤0.01% | 2614 |
|
|
2023
Q1 | $345 | Hold |
4,316
| – | – | ﹤0.01% | 2840 |
|
|
2022
Q4 | $341K | Sell |
4,316
-5
| -0.1% | -$395 | ﹤0.01% | 2772 |
|
|
2022
Q3 | $301K | Buy |
4,321
+31
| +0.7% | +$2.16K | ﹤0.01% | 2826 |
|
|
2022
Q2 | $281K | Buy |
4,290
+772
| +22% | +$50.6K | ﹤0.01% | 2889 |
|
|
2022
Q1 | $234K | Buy |
+3,518
| New | +$234K | ﹤0.01% | 3183 |
|